See more : Logiq, Inc. (LGIQ) Income Statement Analysis – Financial Results
Complete financial analysis of Kim Forest Enterprise Co., Ltd. (6645.TW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Kim Forest Enterprise Co., Ltd., a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- Kolmar Korea Co., Ltd. (161890.KS) Income Statement Analysis – Financial Results
- Mukka Proteins Limited (MUKKA.NS) Income Statement Analysis – Financial Results
- CSB Bancorp, Inc. (CSBB) Income Statement Analysis – Financial Results
- Aarti Pharmalabs Limited (AARTIPHARM.NS) Income Statement Analysis – Financial Results
- China Jinmao Holdings Group Limited (0817.HK) Income Statement Analysis – Financial Results
Kim Forest Enterprise Co., Ltd. (6645.TW)
About Kim Forest Enterprise Co., Ltd.
Kim Forest Enterprise Co., Ltd. provides precision medical products. It offers devices, reagents, and analysis pipelines to health care providers, which include screening tests for cancer and inherited diseases. The company also provides genetic testing, drug report, and monitoring tools for cancer patients; and a non-invasive genome-wide health assessment for healthy persons. In addition, it offers bioinformatics service items; prenatal test kits; and genetically modified models. Further, the company offers SARS-CoV-2 detection kits. The company was founded in 2004 and is headquartered in New Taipei City, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 415.01M | 670.59M | 600.67M | 302.90M | 270.56M |
| Cost of Revenue | 336.40M | 416.64M | 341.20M | 223.59M | 218.92M |
| Gross Profit | 78.61M | 253.95M | 259.47M | 79.30M | 51.64M |
| Gross Profit Ratio | 18.94% | 37.87% | 43.20% | 26.18% | 19.08% |
| Research & Development | 26.89M | 18.69M | 21.62M | 26.70M | 19.21M |
| General & Administrative | 106.88M | 96.30M | 66.53M | 45.93M | 40.69M |
| Selling & Marketing | 70.56M | 65.90M | 58.35M | 39.96M | 35.40M |
| SG&A | 177.44M | 162.20M | 124.87M | 85.89M | 72.79M |
| Other Expenses | 118.00K | 1.78M | 3.61M | 4.29M | -1.00K |
| Operating Expenses | 204.45M | 180.88M | 146.49M | 112.59M | 91.99M |
| Cost & Expenses | 540.84M | 597.52M | 487.69M | 336.18M | 310.92M |
| Interest Income | 608.00K | 250.00K | 32.00K | 31.00K | 59.00K |
| Interest Expense | 2.83M | 1.93M | 1.35M | 2.48M | 3.91M |
| Depreciation & Amortization | 49.28M | 40.96M | 24.54M | 14.39M | 11.17M |
| EBITDA | -72.68M | 116.05M | 141.00M | -15.61M | -29.19M |
| EBITDA Ratio | -17.51% | 17.31% | 23.50% | -4.81% | -10.79% |
| Operating Income | -125.83M | 75.10M | 116.62M | -28.96M | -40.36M |
| Operating Income Ratio | -30.32% | 11.20% | 19.41% | -9.56% | -14.92% |
| Total Other Income/Expenses | 1.05M | -5.73M | -1.51M | -3.51M | 424.00K |
| Income Before Tax | -124.79M | 67.33M | 115.11M | -32.48M | -39.93M |
| Income Before Tax Ratio | -30.07% | 10.04% | 19.16% | -10.72% | -14.76% |
| Income Tax Expense | -22.32M | 24.92M | 25.32M | -6.33M | 8.06M |
| Net Income | -102.47M | 42.42M | 89.44M | -26.15M | -31.87M |
| Net Income Ratio | -24.69% | 6.33% | 14.89% | -8.63% | -11.78% |
| EPS | -2.12 | 0.92 | 1.94 | -0.64 | -0.95 |
| EPS Diluted | -2.12 | 0.91 | 1.91 | -0.64 | -0.95 |
| Weighted Avg Shares Out | 48.40M | 46.00M | 46.18M | 40.88M | 33.55M |
| Weighted Avg Shares Out (Dil) | 48.40M | 46.46M | 46.78M | 40.88M | 33.61M |
Source: https://incomestatements.info
Category: Stock Reports